Pure Global
NCT06227299

INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma

INTEGRAL Study: A Longitudinal Study of Surgeries and Lasers in Glaucoma: Long-term Results and Success Predictors Analysed From a Large-scale Retrospective and Prospective Glaucoma Register
Swiss Glaucoma Research Foundation·ClinicalTrials.govEnrolling by invitation
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Study type
Observational
Sponsor & location
Primary sponsor
Swiss Glaucoma Research Foundation
Location
Lausanne, Switzerland
Timeline & enrollment
Phase
N/A
Start date
May 29, 2018
End date
Jan 01, 2030
Enrollment
5000 participants
Primary outcome

IOP changes,Number of molecules

Summary

The aim of this study is to create a large-scale register of all glaucoma patients diagnosed,
 followed and treated in a large tertiary centre specialising in glaucoma, in order to analyse
 whether specific factors influence the progression of the disease or guide our choice of
 treatment. This should lead to a better understanding of the disease and the factors to be
 taken into account when choosing the best treatment option for each patient, leading to
 safer, more effective and patient-centred care.

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06227299
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06227299 through Pure Global AI's free database. This phase not specified trial is sponsored by Swiss Glaucoma Research Foundation and is currently Enrolling by invitation. The study focuses on Glaucoma. Target enrollment is 5000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.